A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

In the group of elderly patients (≥70 years) with metastatic pancreatic ductal adenocarcinoma (mPDAC), it is not known who benefits from intensive 1st line nab-paclitaxel/gemcitabine (nab-p/gem) combination chemotherapy or who would rather suffer from increased toxicity. We aim to determine whether...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Betge, Johannes (VerfasserIn) , Chi-Kern, Jing (VerfasserIn) , Schulte, Nadine (VerfasserIn) , Belle, Sebastian (VerfasserIn) , Gutting, Tobias (VerfasserIn) , Burgermeister, Elke (VerfasserIn) , Jesenofsky, Ralf (VerfasserIn) , Ebert, Matthias (VerfasserIn) , Härtel, Nicolai (VerfasserIn)
Dokumenttyp:	Article (Journal)
Sprache:	Englisch
Veröffentlicht:	18 July 2018
In:	BMC cancer Year: 2018, Jahrgang: 18
ISSN:	1471-2407
DOI:	10.1186/s12885-018-4665-2
Online-Zugang:	Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12885-018-4665-2 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12885-018-4665-2
Verfasserangaben:	Johannes Betge, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Martin Maenz, Ulrich Wedding, Matthias P. Ebert and Nicolai Haertel

MARC


LEADER	00000caa a2200000 c 4500
001	1580646735
003	DE-627
005	20240316100516.0
007	cr uuu---uuuuu
008	180904s2018 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1186/s12885-018-4665-2 \|2 doi
035			\|a (DE-627)1580646735
035			\|a (DE-576)510646735
035			\|a (DE-599)BSZ510646735
035			\|a (OCoLC)1264006018
040			\|a DE-627 \|b ger \|c DE-627 \|e rda
041			\|a eng
084			\|a 33 \|2 sdnb
100	1		\|a Betge, Johannes \|d 1986- \|e VerfasserIn \|0 (DE-588)108257421X \|0 (DE-627)847674347 \|0 (DE-576)455525021 \|4 aut
245	1	2	\|a A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax) \|c Johannes Betge, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Martin Maenz, Ulrich Wedding, Matthias P. Ebert and Nicolai Haertel
246	3	0	\|a four
264		1	\|c 18 July 2018
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a Gesehen am 04.09.2018
520			\|a In the group of elderly patients (≥70 years) with metastatic pancreatic ductal adenocarcinoma (mPDAC), it is not known who benefits from intensive 1st line nab-paclitaxel/gemcitabine (nab-p/gem) combination chemotherapy or who would rather suffer from increased toxicity. We aim to determine whether treatment individualization by comprehensive geriatric assessments (CGAs) improves functional outcome of the patients.
700	1		\|a Chi-Kern, Jing \|d 1984- \|e VerfasserIn \|0 (DE-588)1052251927 \|0 (DE-627)788088998 \|0 (DE-576)408013168 \|4 aut
700	1		\|a Schulte, Nadine \|d 1981- \|e VerfasserIn \|0 (DE-588)138942404 \|0 (DE-627)703158511 \|0 (DE-576)308939069 \|4 aut
700	1		\|a Belle, Sebastian \|d 1976- \|e VerfasserIn \|0 (DE-588)134303415 \|0 (DE-627)69224140X \|0 (DE-576)278646646 \|4 aut
700	1		\|a Gutting, Tobias \|d 1982- \|e VerfasserIn \|0 (DE-588)1165090708 \|0 (DE-627)1029277370 \|0 (DE-576)510243819 \|4 aut
700	1		\|a Burgermeister, Elke \|d 1968- \|e VerfasserIn \|0 (DE-588)173413455 \|0 (DE-627)704732858 \|0 (DE-576)184247551 \|4 aut
700	1		\|a Jesenofsky, Ralf \|d 1960- \|e VerfasserIn \|0 (DE-588)1029758042 \|0 (DE-627)734019238 \|0 (DE-576)377606448 \|4 aut
700	1		\|a Ebert, Matthias \|d 1968- \|e VerfasserIn \|0 (DE-588)1030133522 \|0 (DE-627)734827083 \|0 (DE-576)377938432 \|4 aut
700	1		\|a Härtel, Nicolai \|d 1977- \|e VerfasserIn \|0 (DE-588)129912913 \|0 (DE-627)483650609 \|0 (DE-576)297899821 \|4 aut
773	0	8	\|i Enthalten in \|t BMC cancer \|d London : BioMed Central, 2001 \|g 18(2018) Artikel-Nummer 747, 7 Seiten \|h Online-Ressource \|w (DE-627)326643710 \|w (DE-600)2041352-X \|w (DE-576)107014645 \|x 1471-2407 \|7 nnas \|a A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)
773	1	8	\|g volume:18 \|g year:2018 \|a A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)
856	4	0	\|u http://dx.doi.org/10.1186/s12885-018-4665-2 \|x Verlag \|x Resolving-System \|z kostenfrei \|3 Volltext
856	4	0	\|u https://doi.org/10.1186/s12885-018-4665-2 \|x Verlag \|z kostenfrei \|3 Volltext
951			\|a AR
992			\|a 20180904
993			\|a Article
994			\|a 2018
998			\|g 129912913 \|a Härtel, Nicolai \|m 129912913:Härtel, Nicolai \|d 60000 \|d 61100 \|e 60000PH129912913 \|e 61100PH129912913 \|k 0/60000/ \|k 1/60000/61100/ \|p 11 \|y j
998			\|g 1030133522 \|a Ebert, Matthias \|m 1030133522:Ebert, Matthias \|d 60000 \|d 61100 \|e 60000PE1030133522 \|e 61100PE1030133522 \|k 0/60000/ \|k 1/60000/61100/ \|p 10
998			\|g 1029758042 \|a Jesenofsky, Ralf \|m 1029758042:Jesenofsky, Ralf \|d 60000 \|d 61100 \|e 60000PJ1029758042 \|e 61100PJ1029758042 \|k 0/60000/ \|k 1/60000/61100/ \|p 7
998			\|g 173413455 \|a Burgermeister, Elke \|m 173413455:Burgermeister, Elke \|d 60000 \|d 61100 \|e 60000PB173413455 \|e 61100PB173413455 \|k 0/60000/ \|k 1/60000/61100/ \|p 6
998			\|g 1165090708 \|a Gutting, Tobias \|m 1165090708:Gutting, Tobias \|d 60000 \|d 61100 \|e 60000PG1165090708 \|e 61100PG1165090708 \|k 0/60000/ \|k 1/60000/61100/ \|p 5
998			\|g 134303415 \|a Belle, Sebastian \|m 134303415:Belle, Sebastian \|d 60000 \|d 61100 \|e 60000PB134303415 \|e 61100PB134303415 \|k 0/60000/ \|k 1/60000/61100/ \|p 4
998			\|g 138942404 \|a Schulte, Nadine \|m 138942404:Schulte, Nadine \|d 60000 \|d 61100 \|e 60000PS138942404 \|e 61100PS138942404 \|k 0/60000/ \|k 1/60000/61100/ \|p 3
998			\|g 1052251927 \|a Chi-Kern, Jing \|m 1052251927:Chi-Kern, Jing \|p 2
998			\|g 108257421X \|a Betge, Johannes \|m 108257421X:Betge, Johannes \|d 60000 \|d 61100 \|e 60000PB108257421X \|e 61100PB108257421X \|k 0/60000/ \|k 1/60000/61100/ \|p 1 \|x j
999			\|a KXP-PPN1580646735 \|e 3024679340
BIB			\|a Y
SER			\|a journal
JSO			\|a {"relHost":[{"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 22.05.20"],"id":{"eki":["326643710"],"issn":["1471-2407"],"zdb":["2041352-X"]},"part":{"year":"2018","text":"18(2018) Artikel-Nummer 747, 7 Seiten","volume":"18"},"title":[{"title":"BMC cancer","title_sort":"BMC cancer"}],"origin":[{"dateIssuedKey":"2001","publisherPlace":"London ; Berlin ; Heidelberg","dateIssuedDisp":"2001-","publisher":"BioMed Central ; Springer"}],"pubHistory":["1.2001 -"],"disp":"A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)BMC cancer","physDesc":[{"extent":"Online-Ressource"}],"recId":"326643710"}],"person":[{"display":"Betge, Johannes","family":"Betge","given":"Johannes","role":"aut"},{"family":"Chi-Kern","given":"Jing","role":"aut","display":"Chi-Kern, Jing"},{"family":"Schulte","role":"aut","given":"Nadine","display":"Schulte, Nadine"},{"display":"Belle, Sebastian","family":"Belle","role":"aut","given":"Sebastian"},{"display":"Gutting, Tobias","role":"aut","given":"Tobias","family":"Gutting"},{"family":"Burgermeister","given":"Elke","role":"aut","display":"Burgermeister, Elke"},{"given":"Ralf","role":"aut","family":"Jesenofsky","display":"Jesenofsky, Ralf"},{"display":"Ebert, Matthias","family":"Ebert","given":"Matthias","role":"aut"},{"display":"Härtel, Nicolai","family":"Härtel","role":"aut","given":"Nicolai"}],"name":{"displayForm":["Johannes Betge, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Martin Maenz, Ulrich Wedding, Matthias P. Ebert and Nicolai Haertel"]},"origin":[{"dateIssuedDisp":"18 July 2018","dateIssuedKey":"2018"}],"note":["Gesehen am 04.09.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)","title_sort":"multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)"}],"id":{"doi":["10.1186/s12885-018-4665-2"],"eki":["1580646735"]},"recId":"1580646735"}
SRT			\|a BETGEJOHANMULTICENTE1820

A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

MARC

Ähnliche Einträge